Exploring the presence of narcolepsy in patients with schizophrenia.

about

Schizophrenia and sleep disorders: links, risks, and management challenges

P2860

Q42364468-61C1EF5F-F77A-4586-8B08-FBFF2E4665B9

P2860

Exploring the presence of narcolepsy in patients with schizophrenia.

Item

http://www.wikidata.org/entity/Q36955561

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Exploring the presence of narcolepsy in patients with schizophrenia.

@en

type

Item

label

Exploring the presence of narcolepsy in patients with schizophrenia.

@en

prefLabel

Exploring the presence of narcolepsy in patients with schizophrenia.

@en

P1476

Exploring the presence of narcolepsy in patients with schizophrenia

@en

P2093

Alba Gavaldà

http://www.w3.org/2001/XMLSchema#string

Alex Iranzo

http://www.w3.org/2001/XMLSchema#string

Carles Gaig

http://www.w3.org/2001/XMLSchema#string

Gemma Sansa

http://www.w3.org/2001/XMLSchema#string

Gisela Ribera

http://www.w3.org/2001/XMLSchema#string

Guadalupe Ercilla

http://www.w3.org/2001/XMLSchema#string

Joan Santamaria

http://www.w3.org/2001/XMLSchema#string

Roser Casamitjana

http://www.w3.org/2001/XMLSchema#string

P2860

Schizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country Study

Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior

The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity

A new method for measuring daytime sleepiness: the Epworth sleepiness scale

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features.

Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort.

Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders.

The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.

Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.

P2888

s12888-016-0859-9

P304

177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12888-016-0859-9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

JOSE ANTONIO MONREAL-ORTIZ

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1001519834

http://www.w3.org/2001/XMLSchema#string

P698

27245445

http://www.w3.org/2001/XMLSchema#string

P921

narcolepsy

schizophrenia

P932

4888670

http://www.w3.org/2001/XMLSchema#string

Exploring the presence of narcolepsy in patients with schizophrenia.

about

P2860

P2860

Exploring the presence of narcolepsy in patients with schizophrenia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P6179

P698

P921

P932